Core Laboratories (CLB) Total Non-Current Liabilities (2022 - 2026)

Core Laboratories' Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $571.9 million for Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 1.17% year-over-year to $571.9 million in Q1 2026; TTM through Mar 2026 was $571.9 million, a 1.17% increase from a year earlier, with the FY2025 full-year figure at $568.2 million, up 0.67% from the prior year.
• Total Non-Current Liabilities rose to $571.9 million in Q1 2026 per CLB's latest filing, from $568.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $582.8 million in Q2 2023 and bottomed at $557.5 million in Q4 2022.
• The 5-year median for Total Non-Current Liabilities is $571.9 million (2026), against an average of $571.9 million.
• Across the five-year window, Total Non-Current Liabilities rose 1.59% in 2023 and fell 2.14% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $557.5 million in 2022, then grew by 1.59% to $566.4 million in 2023, then dropped by 0.35% to $564.4 million in 2024, then gained by 0.67% to $568.2 million in 2025, then increased by 0.65% to $571.9 million in 2026.
• Per Business Quant, the three latest CLB Total Non-Current Liabilities figures stand at $571.9 million (Q1 2026), $568.2 million (Q4 2025), and $569.9 million (Q3 2025).